Peptide Therapeutics Limited
Records under this name other than patents Peptide Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Peptide Therapeutics Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,326,917 | Scanner-control device Formerly held Term ended Term ended May 15, 2020 · USPTO record | Term ended | Term ended May 15, 2020 | USPTO record |
| US 6,034,066 | Cysteine protease inhibitors for use in treatment of IGE mediated allergic diseases Formerly held Term ended Term ended Feb 26, 2018 · USPTO record | Term ended | Term ended Feb 26, 2018 | USPTO record |
| US 6,902,906 | Bacteria attenuated by a non-reverting mutation in each of the aroC, ompF and ompC genes, useful as vaccines Formerly held Lapsed on the fee record Ended Jun 7, 2017 · USPTO record | Lapsed on the fee record | Ended Jun 7, 2017 | USPTO record |
| US 6,528,275 | Substrates and inhibitors of proteolytic enzymes Formerly held Lapsed on the fee record Ended Mar 4, 2015 · USPTO record | Lapsed on the fee record | Ended Mar 4, 2015 | USPTO record |
| US 6,372,885 | Solid-phase technology for the preparation of amides Formerly held Lapsed on the fee record Ended Apr 16, 2014 · USPTO record | Lapsed on the fee record | Ended Apr 16, 2014 | USPTO record |
| US 6,680,182 | Expression of recombinant fusion proteins in attenuated bacteria Formerly held Lapsed on the fee record Ended Jan 20, 2012 · USPTO record | Lapsed on the fee record | Ended Jan 20, 2012 | USPTO record |
| US 7,169,399 | Non-toxic double mutant forms of pertussis toxin as adjuvants Formerly held Lapsed on the fee record Ended Jan 30, 2011 · USPTO record | Lapsed on the fee record | Ended Jan 30, 2011 | USPTO record |
| US 5,601,821 | Immunoactive peptides and antibodies and their use in anti-allergy treatment Term ended Term ended no later than Feb 11, 2017 · Low confidence | Term ended | Term ended no later than Feb 11, 2017 | Low confidence |
| US 5,827,668 | Immunodiagnostic assay for rheumatoid arthritis Term ended Term ended no later than Oct 27, 2018 · Low confidence | Term ended | Term ended no later than Oct 27, 2018 | Low confidence |
| US 5,837,686 | Peptides and antibodies for treatment of rheumatoid arthritis Term ended Term ended no later than Nov 17, 2018 · Low confidence | Term ended | Term ended no later than Nov 17, 2018 | Low confidence |